Article Information
History
- September 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Chiara Giuliano1,2,*,
- Lucia Marti-Prats1,*,
- Ana Domi1,3,
- Mickaël Puaud1,
- Yolanda Pena-Oliver1,4,
- Colin McKenzie1,
- Barry J. Everitt1 and
- David Belin1,†
- 1Behavioural and Clinical Neuroscience Institute and Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, UK
- 2Astra Zeneca, R&D Biopharmaceuticals, Fleming Building (B623), Babraham Research Park, Babraham, Cambridgeshire CB22 3AT, UK
- 3Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg, Box 410, Gothenburg 405 30, Sweden
- 4Research and Enterprise Services, University of Sussex, Brighton, UK
- ↵†Corresponding author: Dr David Belin, Department of Psychology, University of Cambridge, Downing St., Cambridge CB2 3EB, UK, Tel. +44 (0)1223333588, Fax. +44 (0)1223 333564, email: bdb26{at}cam.ac.uk